Answers are grounded in this paper and cite their sources.
Abstract ID 129952 Poster Board 216 Under basal physiological conditions, platelets circulate in the blood in an inactive state and have on their surface different types of granules (fundamentally granules, α-granules and lysosomes which, in an active state, release different factors stored in them and which in turn factors stored in them, which in turn further stimulate the activity of the platelet itself. In other words, they will facilitate their interaction with other platelets, with other cells or foreign agents in their environment. Once activated, platelets go through three critical stages, such as adhesion, activation and aggregation. In turn, they form a hemostatic plug and endothelial damage by adhering to the vascular wall, causing activation of the coagulation cascade. Thus, it is suggested that platelets may interact with quantum dots and cause various effects that interfere with primary hemostasis. The aim of this work is to evaluate the effect of cellular uptake of dextrin capped cadmium sulfide quantum dots (CdS-dex QDs) with platelets and its related effect on hemostasis function. To determinate the effect of CdS-Dex QDs interaction on platelet aggregation we obtained plasma. Blood was carefully obtained and placed in a tube with 3.2% sodium citrate anticoagulant (0.109 M). To obtained platelet-rich plasma (PRP), it was centrifuged at 1000 rpm for 15 minutes and the supernatant was collected. As a positive control for platelet aggregation collagen at a concentration of 0.19 mg/mL and a control group without treatment. Platelets were treatment with CdS-Dex QDs at concentrations of 0.01, 0.1, 1, 1, 10, 100 and 1000 μg/mL and incubated again for 30 minutes. After this time, we analyzed in a spectrophotometer at a wavelength of 550 nm. To determinate of the uptake and intracellular localization of CdS-Dex QDs in platelets by fluorescence confocal microscopy. We obtained platelets from healthy rats, aliquots of approximately 10 μL were taken and dry smears were performed. Then, on a slide, a drop of 10% glycerol was placed on a slide and the coverslip was fixed so that the cell monolayer was on the drop. Finally, photographs were taken in visible, fluorescence, superimposition (Olympus FV100 Inverted Confocal Microscope for high-resolution (3D) and used for topographic analysis by atomic force microscopy (AFM) (XE-Bio atomic force microscope (Park Systems Co. (Park Systems Co., Suwan, Korea). The CdS-Dex QDs caused platelet aggregation between 36 and 40% from the concentration of 0.01 to 100 μg/mL (p < 0.05), compared to the control group. At 1000 μg/mL concentration this effect increased up to 57%, significant with respect to the control group. The CdS-Dex QDs caused platelet aggregation in a concentration-dependent manner starting at 0.01 μg/mL. Although cellular uptake was observed from the concentration of 1000 ug/mL. However, platelet morphology was observed to be affected from low concentrations of 0.01 ug/mL with the greatest effect at the 1000 ug/mL concentration. Some nanomaterials may generate a new toxicological profile and should be evaluated from scratch. The results of our research extend the importance of evaluating the hemocompatibility of quantum dots from all available cellular angles, to pharmacological and toxicological scopes. However, I believe that the value of understanding QD-blood cell interactions goes beyond improving the design of QDs. Nonetheless, evaluating such interactions with blood components allows us to use these interactions for theranostic purposes.
No takes yet. Share an insight, caveat, or question.
Rodríguez‐Fragoso et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: